Cellphire

Cellphire Therapeutics, Inc. is a biotechnology company developing next-generation platelet-based therapeutics. The company is applying its proprietary cell stabilization technology to platelets, to develop lifesaving products. Its lead investigational product is Thrombosomes®, a freeze-dried hemostatic derived from human platelets. Cellphire is expanding its technology portfolio to include a wide range of potential medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.